Feb 3, 2026 · BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for …

3 days ago · BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture and commercialization of allografts for …

BioStem Technologies, Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived allografts for advanced wound care.

Learn more about BioStem, makers of VENDAJE®, VENDAJE AC® and VENDAJE Optic® perinatal allografts as well as AmnioWrap2.

The patented six-step BioREtain® process is gentle, minimally invasive, & preserves the natural integrity of the amniotic tissue components.

Nov 13, 2025 · BioStem Technologies® to Debut American Amnion (TM) at the 2025 Desert Foot Multi-Disciplinary Limb Salvage and Wound Care Conference November 25, 2025

Jan 8, 2025 · BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts.

May 28, 2025 · BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts.

Oct 30, 2024 · About BioStem Technologies, Inc. (OTC: BSEM): BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, …

Get in touch with the leader in amniotic tissue allografts. Visit the BioStem contact page call or email us for more information.